SE397827B - Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan

Info

Publication number
SE397827B
SE397827B SE7316178A SE7316178A SE397827B SE 397827 B SE397827 B SE 397827B SE 7316178 A SE7316178 A SE 7316178A SE 7316178 A SE7316178 A SE 7316178A SE 397827 B SE397827 B SE 397827B
Authority
SE
Sweden
Prior art keywords
cyclopropancarboxamide
aminomethyl
diphenyl
derivatives
procedure
Prior art date
Application number
SE7316178A
Other languages
English (en)
Swedish (sv)
Inventor
J-C Cognaco
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie filed Critical Hexachimie
Publication of SE397827B publication Critical patent/SE397827B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
SE7316178A 1972-11-30 1973-11-29 Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan SE397827B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5527672A GB1415541A (en) 1972-11-30 1972-11-30 1-amino-methyl-2,2-diarylcyclopropanecarboxamide

Publications (1)

Publication Number Publication Date
SE397827B true SE397827B (sv) 1977-11-21

Family

ID=10473454

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7316178A SE397827B (sv) 1972-11-30 1973-11-29 Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan

Country Status (20)

Country Link
US (1) US3989722A (un)
JP (2) JPS504045A (un)
AR (1) AR206508A1 (un)
AT (1) AT327167B (un)
BE (1) BE807627A (un)
CA (1) CA960666A (un)
CH (1) CH583179A5 (un)
CS (1) CS168684B2 (un)
DD (1) DD109213A5 (un)
DE (1) DE2359820A1 (un)
DK (1) DK137639B (un)
ES (1) ES421018A1 (un)
FR (1) FR2208661B1 (un)
GB (1) GB1415541A (un)
HU (1) HU167290B (un)
NL (1) NL7316486A (un)
NO (1) NO139917C (un)
SE (1) SE397827B (un)
SU (1) SU488402A3 (un)
ZA (1) ZA738837B (un)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5243038A (en) * 1975-10-03 1977-04-04 Hitachi Ltd Mold type ignition coil
JPS5312079A (en) * 1976-07-20 1978-02-03 Fujitsu Ltd Method of producing multilayer printed board
JPS5330776A (en) * 1976-09-01 1978-03-23 Fujitsu Ltd Method of forming pattern on embedded land copper stacking board
US4202902A (en) * 1979-03-05 1980-05-13 Shell Oil Company Lipogenesis control by cyclopropane-carboxylic acids, esters and amides
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2759290B1 (fr) * 1997-02-13 2004-06-18 Pf Medicament Minalcipran pour le traitement de l'incontinence urinaire
US20090203750A1 (en) * 2005-08-24 2009-08-13 Alan Kozikowski 5-HT2C Receptor Agonists as Anorectic Agents
FR3139202B1 (fr) 2022-08-30 2024-07-12 Psa Automobiles Sa Procédé et dispositif de détection d’obstacle pour un véhicule avec un capteur radar

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3098076A (en) * 1958-08-26 1963-07-16 Burroughs Wellcome Co 1, 1-diphenyl-2-tertiary aminomethyl-3-hydroxy methyl-cyclopropanes and esters thereof
US3423461A (en) * 1965-10-19 1969-01-21 Smithkline Corp 2-amino- or aminoalkylene-10',11'-dihydrospiro(cyclopropane - 1,5' - 5h-dibenzo-(a,d)cycloheptenes) and the salts thereof
GB1167711A (en) * 1966-01-26 1969-10-22 Whitefin Holding Sa Diarylcyclopropane Derivatives
US3646146A (en) * 1967-01-17 1972-02-29 Whitefin Holding Sa Diphenylcyclopropyl-methyl-amines
US3574742A (en) * 1968-06-25 1971-04-13 American Home Prod Aminoalicyclic carboxhydrazides
FR2171947A1 (en) * 1972-02-16 1973-09-28 Hexachimie Substd aminomethyl -2,2- diaryl cyclopropanes - for treating anxiety and cardiac insufficiency

Also Published As

Publication number Publication date
CH583179A5 (un) 1976-12-31
NL7316486A (un) 1974-06-04
DE2359820A1 (de) 1974-06-06
DK137639B (da) 1978-04-10
JPS504045A (un) 1975-01-16
JPS504046A (un) 1975-01-16
CS168684B2 (un) 1976-06-29
AT327167B (de) 1976-01-26
FR2208661B1 (un) 1976-09-03
AU6304873A (en) 1975-05-29
FR2208661A1 (un) 1974-06-28
ZA738837B (en) 1974-10-30
DD109213A5 (un) 1974-10-20
SU488402A3 (ru) 1975-10-15
AR206508A1 (es) 1976-07-30
ATA938673A (de) 1975-04-15
BE807627A (fr) 1974-03-15
ES421018A1 (es) 1976-05-01
NO139917C (no) 1979-06-06
HU167290B (un) 1975-09-27
GB1415541A (en) 1975-11-26
US3989722A (en) 1976-11-02
DK137639C (un) 1978-09-18
CA960666A (en) 1975-01-07
NO139917B (no) 1979-02-26

Similar Documents

Publication Publication Date Title
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE407575B (sv) Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE402102B (sv) Forfarande for framstellning av 4-amino-n-(1-cyklohexyl-3-pyrrolidinyl)-n-alkyl-bensamider, med verdefulla terapeutiska egenskaper
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan